Breaking News Instant updates and real-time market news.

AXGN

AxoGen

$17.56

0.45 (2.63%)

07:21
08/07/19
08/07
07:21
08/07/19
07:21

AxoGen downgraded to Market Perform from Outperform at William Blair

William Blair analyst Brian Weinstein downgraded AxoGen to Market Perform from Outperform.

  • 07

    Aug

  • 14

    Aug

  • 09

    Sep

AXGN AxoGen
$17.56

0.45 (2.63%)

03/25/19
BTIG
03/25/19
UPGRADE
Target $28
BTIG
Buy
AxoGen upgraded to Buy from Neutral at BTIG
BTIG analyst Ryan Zimmerman upgraded AxoGen to Buy with a price target of $28, citing the stabilizing of its sales force based on his analysis of LinkedIn data and expectations that the management will have learned from its past mistakes by offering a more conservative guidance. The analyst also believes that AxoGen could become an M&A target since its potential acquirers have improved leverage ratios and have discussed deploying capital. Moreover, Zimmerman anticipates AxoGen's Avance nerve graft platform to be granted a Biologics License Application status by the FDA, but even in its absence, the analyst contends the company "isn't limited from selling Avance under 361 HCT/P," or Human cells, tissues, or cellular or tissue-based products regulations.
05/09/19
CANT
05/09/19
NO CHANGE
Target $30
CANT
Overweight
AxoGen price target raised to $30 from $26 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou raised his price target for AxoGen to $30 from $26 saying the company's Q1 growth was a "strong start to the year and a big first step to restore investor confidence." He reiterates an Overweight rating on the shares.
07/12/19
ADAM
07/12/19
INITIATION
Target $32
ADAM
Buy
AxoGen initiated with a Buy at Canaccord
Canaccord analyst Kyle Rose initiated AxoGen with a Buy rating and $32 price target. In a research note to investors, Rose says he believes the investments in the commercial team, market development initiatives and clinical trials position the company to reaccelerate growth into the second half of 2019. Rose says he feels the current valuation represents a compelling entry point, with top-line growth exceeding 30%, a strong balance sheet an an "exceptional" gross margin profile.
08/07/19
CANT
08/07/19
NO CHANGE
Target $21
CANT
Overweight
AxoGen price target lowered to $21 from $30 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou lowered his price target for AxoGen to $21 from $30 after the company reduced its 2019 sales due to delayed productivity growth. While the analyst remains concerned about the trend in top-line growth and the different salesforce issues over the last year, he thinks the revised guidance is achievable. Amid the expected selloff today, Bijou sees a favorable risk/reward on the shares and keeps an Overweight rating on AxoGen.

TODAY'S FREE FLY STORIES

AEO

American Eagle

$16.55

-0.44 (-2.59%)

17:33
09/17/19
09/17
17:33
09/17/19
17:33
Initiation
American Eagle initiated  »

American Eagle initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CACI

CACI

$216.89

0.91 (0.42%)

17:30
09/17/19
09/17
17:30
09/17/19
17:30
Upgrade
CACI rating change  »

CACI added to Conviction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

ANF

Abercrombie & Fitch

$16.25

0.08 (0.49%)

17:29
09/17/19
09/17
17:29
09/17/19
17:29
Initiation
Abercrombie & Fitch initiated  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FB

Facebook

$188.13

1.89 (1.01%)

, GOOG

Alphabet

$1,229.61

-1.75 (-0.14%)

17:28
09/17/19
09/17
17:28
09/17/19
17:28
Periodicals
U.S. antitrust regulators admit to 'squabbles' amid Big Tech probe, Reuters says »

U.S. regulators concede…

FB

Facebook

$188.13

1.89 (1.01%)

GOOG

Alphabet

$1,229.61

-1.75 (-0.14%)

AMZN

Amazon.com

$1,822.59

14.38 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

  • 27

    Oct

T

AT&T

$37.16

-0.16 (-0.43%)

17:25
09/17/19
09/17
17:25
09/17/19
17:25
Hot Stocks
AT&T sees wireless service revenue growth continuing in second half of 2019 »

Randall Stephenson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CDW

CDW

$113.91

0.94 (0.83%)

, TSS

TSYS

$132.86

-1.7 (-1.26%)

17:17
09/17/19
09/17
17:17
09/17/19
17:17
Hot Stocks
CDW to replace TSYS in S&P 500 at open on 9/23 »

Global Payments (GPN) is…

CDW

CDW

$113.91

0.94 (0.83%)

TSS

TSYS

$132.86

-1.7 (-1.26%)

GPN

Global Payments

$163.91

-2.21 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

STBA

S&T Bancorp

$37.22

-0.17 (-0.45%)

17:16
09/17/19
09/17
17:16
09/17/19
17:16
Hot Stocks
S&T Bancorp board authorizes new $50M stock buyback »

The board of S&T…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$173.53

-0.14 (-0.08%)

17:12
09/17/19
09/17
17:12
09/17/19
17:12
Downgrade
FedEx rating change  »

FedEx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

NEXT

NextDecade

$6.30

-0.1 (-1.56%)

17:10
09/17/19
09/17
17:10
09/17/19
17:10
Initiation
NextDecade initiated  »

NextDecade initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELL

Tellurian

$8.33

-0.1 (-1.19%)

17:10
09/17/19
09/17
17:10
09/17/19
17:10
Initiation
Tellurian initiated  »

Tellurian initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLNK

NewLink Genetics

$1.90

-0.03 (-1.55%)

, MRK

Merck

$82.53

0.52 (0.63%)

17:06
09/17/19
09/17
17:06
09/17/19
17:06
Hot Stocks
NewLink Genetics says FDA accepts partnered BLA for ebola vaccine »

NewLink Genetics…

NLNK

NewLink Genetics

$1.90

-0.03 (-1.55%)

MRK

Merck

$82.53

0.52 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 29

    Oct

ESTC

Elastic

$93.80

2.15 (2.35%)

17:03
09/17/19
09/17
17:03
09/17/19
17:03
Hot Stocks
Elastic selected by New Zealands'The Warehouse for its customer service program »

Elastic N.V. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

TOL

Toll Brothers

$40.68

-0.11 (-0.27%)

17:00
09/17/19
09/17
17:00
09/17/19
17:00
Hot Stocks
Toll Brothers CEO sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$43.88

0.51 (1.18%)

16:56
09/17/19
09/17
16:56
09/17/19
16:56
Hot Stocks
Aqua America subsidiary to buy municipal wastewater system for $276.5M »

Aqua America announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$28.49

0.31 (1.10%)

16:54
09/17/19
09/17
16:54
09/17/19
16:54
Syndicate
Invitation Homes files to sell 44M shares of common stock for holders »

Morgan Stanley, Citigroup…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MODN

Model N

$28.43

0.275 (0.98%)

, IQV

Iqvia

$152.93

2.14 (1.42%)

16:49
09/17/19
09/17
16:49
09/17/19
16:49
Hot Stocks
Model N names Suresh Kannan as Chief Product Officer »

Model N (MODN) announced…

MODN

Model N

$28.43

0.275 (0.98%)

IQV

Iqvia

$152.93

2.14 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 08

    Oct

  • 12

    Nov

GWW

Grainger

$291.76

-4.29 (-1.45%)

16:49
09/17/19
09/17
16:49
09/17/19
16:49
Conference/Events
Grainger management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 23

    Oct

ACGL

Arch Capital

$40.89

0.33 (0.81%)

16:48
09/17/19
09/17
16:48
09/17/19
16:48
Conference/Events
Arch Capital management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

TOL

Toll Brothers

$40.68

-0.11 (-0.27%)

16:47
09/17/19
09/17
16:47
09/17/19
16:47
Hot Stocks
Toll Brothers president Hartman sells over 40,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$28.56

0.31 (1.10%)

16:45
09/17/19
09/17
16:45
09/17/19
16:45
Hot Stocks
VA Partners reports 8.8% stake in KKR »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

ADBE

Adobe

$284.59

1.54 (0.54%)

16:44
09/17/19
09/17
16:44
09/17/19
16:44
Hot Stocks
Adobe down 3.5% at $274.65/share after reducing Digital Experience bookings view »

Shares of Adobe are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Oct

  • 27

    Oct

16:41
09/17/19
09/17
16:41
09/17/19
16:41
General News
API crude inventories for week of September 13 »

API reports that crude…

CAL

Caleres

$22.08

-0.71 (-3.12%)

16:35
09/17/19
09/17
16:35
09/17/19
16:35
Hot Stocks
Caleres appoints Angela Bass as Chief Human Resources Officer »

Caleres announced Angela…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 02

    Oct

CHSP

Chesapeake Lodging

$27.20

-0.2 (-0.73%)

, PK

Park Hotels & Resorts

$25.80

-0.32 (-1.23%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Hot Stocks
Chesapeake Lodging completes sale of two new York hotels for $138M »

Chesapeake Lodging Trust…

CHSP

Chesapeake Lodging

$27.20

-0.2 (-0.73%)

PK

Park Hotels & Resorts

$25.80

-0.32 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAE

CAE

$25.54

0.4 (1.59%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Conference/Events
CAE management to meet with CIBC »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.